Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata may be caused by antibodies targeting specific hair follicle proteins, hindering hair growth.

Alopecia areata involves unique activation of certain immune cells.

A simple test can help diagnose a rare bruising disorder after ruling out other causes.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Autoimmune-related phenomena do not affect the progression or characteristics of lichen sclerosus in women.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Autoimmune gastritis is a common cause of iron deficiency and should be included in diagnostic guidelines.

Genetic screening is crucial for accurately diagnosing APS-1 due to its varied symptoms.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

Autoimmunity can cause both alopecia areata and idiopathic primary hypophysitis.

Anti-Ku antibodies are linked to unique symptoms and may involve autophagy issues.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Patients with alopecia areata should be checked for muscle spasms, diarrhea, and ANA to avoid missing Satoyoshi syndrome.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

The document concludes that systemic autoimmune diseases are complex, incurable, and require ongoing treatment and research.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Managing multiple autoimmune diseases in one patient is very challenging.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

The role of γδT-cells in causing alopecia areata remains unclear.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

A 16-year-old boy had pernicious anemia, autoimmune hemolytic anemia, and later developed alopecia areata.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.